Atomo Diagnostics
Follow
Get notifications in MyBN when activity occurs.
Industry Lists
Public Companies - non WAAtomo Diagnostics (AT1) is a medical device company that is establishing an in-house assembly and packing facility in South Africa, and has a commercial office in the UK.
Its Rapid Diagnostic Test devices are used by healthcare professionals and consumers to screen for a range of diseases and medical conditions, including HIV infection.
Contact Details
Level 2, 701-703 Parramatta Road, LEICHHARDT NSW 2040
02 9099 4750
Lists and Charts
Share price
Closing price for the last 90 trading days
Powered by Morningstar ®
Total Shareholder Return as at 31/10/24
| Rank | Company | 1 yr | 5 yr |
|---|---|---|---|
| 778th | Atomo Diagnostics | 5% |
1740 WA (and selected non WA) listed companies ranked by
1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®
1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®
Revenue
| Rank | Company | Revenue | |
|---|---|---|---|
| th |  | Atomo Diagnostics | $5.1m |
1333 listed non wa companies ranked by revenue.
Powered by Morningstar ®
Powered by Morningstar ®
Share Transactions
Total value as at the date of the transaction
Powered by Morningstar ®
Company Activity
| NEW ROLE: Cheri Walker, Non-Executive Director | 11 Jul 2024 |
| NEW ROLE: Chandra Sukumar, | 03 Nov 2022 |
| NEW ROLE: Deborah Neff, Non-Executive Director | 20 Sep 2021 |
| NEW ROLE: Fabio Baglioni, Chief Commercial Officer | 24 Nov 2020 |
| NEW ROLE: William Souter, Chief Financial Officer | 24 Nov 2020 |
| NEW ROLE: Mark Smith, Chief Operating Officer | 24 Nov 2020 |
| NEW ROLE: Gillian Nairn, Company Secretary | 03 Nov 2020 |
| NEW ROLE: Paul Kasian, Non-Executive Director | 03 Nov 2020 |
| NEW ROLE: Connie Carnabuci, Non-Executive Director | 03 Nov 2020 |
